Concepedia

Mazen Tolaymat

MT

Statistics

Publications

3

Citations

51

H-Index

3

Active since

2017

Affiliations

University of Maryland, Baltimore(Current)

Mazen Tolaymat is an author at University of Maryland, Baltimore specializing in medicine, drug utilization evaluation, and inflammatory bowel disease therapy.

ORCID

Publications per year

2017–2023

3

Publications

3

Proactive Drug Monitoring Is Associated With Higher Persistence to Infliximab and Adalimumab Treatment and Lower Healthcare Utilization Compared With Reactive and Clinical Monitoring

Nauroz Syed, Mazen Tolaymat, Sara Brown et al. · Crohn s & Colitis 360 · 2020 · 28 citations · Full text

, , +17

Prevalence and Risk Factors for Choledocholithiasis After Cholecystectomy

Joseph Spataro, Mazen Tolaymat, Charles Kistler et al. · The American Journal of Gastroenterology · 2017 · 12 citations

, , +16

Muscarinic receptor agonist-induced βPix binding to β-catenin promotes colon neoplasia

Kunrong Cheng, Ahmed Chahdi, Shannon M. Larabee et al. · Scientific Reports · 2023 · 11 citations · Full text

, , +17

1–3 of 3